EGFR and lung cancer: Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel <i>EGFR</i> Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases.